Suggest Edits

Be The First To
Add Photos

Headquarters San Diego, CA
Size 150 to 499 Employees
Founded Unknown
Type Company - Public
Industry Biotech & Pharmaceuticals
Revenue ₹5 to ₹10 billion (INR) per year

Santarus is a bit controlling, but in this case it's okay. Santarus' flagship drug Glumetza improves glycemic control for type 2 diabetes patients and is marketed through a partnership with Depomed. It markets a similar drug, Cycloset, also to improve glycemic control for type 2 diabetes, through a distribution and license agreement with S2 Therapeutics and Veroscience. Santarus' lead product used to be Zegerid, a modified version of omeprazole, the proton pump inhibitor found in AstraZeneca's best-selling Prilosec for heartburn. But when Zegerid's patent ran out and its... More

Working at Santarus

Posted by employees

Employees are “Satisfied”   12 ratings

3.7

82% Approve of the CEO   9 ratings

Santarus President, CEO, and Director Gerald T. Proehl

Gerald T. Proehl

President, CEO, and Director

Best place I have ever worked

  Former Employee

Pros: Fantastic company culture. I felt highly valued and appreciated. I learned more at this company than at any other I've ever worked at. Full Review

More Santarus Ratings & Reviews ( 12)

Accepted Offer – Reviewed Jan 16, 2014

Interview Details Phone interview with local inVentiv recruiter, phone interview with hiring District Sales Manager, face to face interview with Regional Sales Director, hiring District Sales Manager, and inVentiv ERM.Full Interview

Interview Question:
Give me a growth opportunity for you? Answer Question

More Santarus Interview Questions & Reviews (2)

Santarus Awards and Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Worked for Santarus? Contribute to the Community!